European Hematology Association(@EHA_Hematology) 's Twitter Profile Photo

From learning new skills to developing your own research project, Clinical Research Training in Hematology ( ) is a chance to advance your career. Hear from C Lecat, past CRTH scholar about her experience 👇
Learn more: eha.fyi/CRTH25

account_circle
CAMP4 Therapeutics(@camp4tx) 's Twitter Profile Photo

We’re pleased to announce that the first participant has been dosed in the Phase 1 of CMP-CPS-001, our first-in-class therapeutic for the potential treatment of (UCDs).

📢 Learn more: bit.ly/4csWzeA

account_circle
UF Diabetes Institute(@ufdiabetes) 's Twitter Profile Photo

Exciting news! 🌟 The TrialNet New Onset Studies for Type 1 Diabetes are now open for enrollment at the University of Florida. Join us in advancing research and making strides in diabetes treatment. Be a part of the journey!

account_circle
WallStreetBets & Co.(@WSBConsensus) 's Twitter Profile Photo

Safety Shot ( $SHOT ) has been leading the way in scientific development with their groundbreaking double-blind, placebo-controlled trial.

Results expected in Q1 2024 (which is coming to an end)

Get ready to feel better faster!

@drinksafetyshot ( $SHOT ) has been leading the way in scientific development with their groundbreaking double-blind, placebo-controlled trial.

Results expected in Q1 2024 (which is coming to an end)

Get ready to feel better faster!

#SafetyShot #ClinicalTrial #FeelBetterFaster
account_circle
OncoDaily(@oncodaily) 's Twitter Profile Photo

Datopotamab deruxtecan – another anti-TROP2 conjugate demonstrating activity in advanced ER+/HER2- and triple-negative breast cancer patients - Piotr Wysocki

oncodaily.com/56332.html

account_circle
UM Neurosurgery(@UMneurosurgery) 's Twitter Profile Photo

Exciting news!
Learn about the latest advancements in this novel virotherapy treatment and its potential impact on battling this challenging disease.
For more information please visit:
shahlab.squarespace.com/general-2 (shahlab.squarespace.com/general-2)

account_circle
Naveen Sankar S(@NaveenSankarS) 's Twitter Profile Photo

A phase 2 trial reveals that daily 81 mg aspirin significantly reduces liver fat in patients with metabolic dysfunction–associated steatotic liver disease (MASLD) at 6 months compared to placebo

Findings are preliminary & need further confirmation.

A phase 2 trial reveals that daily 81 mg aspirin significantly reduces liver fat in patients with metabolic dysfunction–associated steatotic liver disease (MASLD) at 6 months compared to placebo 

Findings are preliminary & need further confirmation. #LiverHealth #ClinicalTrial
account_circle
Volastra Therapeutics(@VolastraTx) 's Twitter Profile Photo

Join us at the 2024 ASCO Annual Meeting next month! We look forward to sharing details from our ongoing investigating VLS-1488, our internally discovered inhibitor, for the treatment of advanced .

Join us at the 2024 @ASCO Annual Meeting next month! We look forward to sharing details from our ongoing #clinicaltrial investigating VLS-1488, our internally discovered #KIF18A inhibitor, for the treatment of advanced #cancers.
#ASCO24
account_circle
Yvonne Diaz(@Yvonne_Diaz_) 's Twitter Profile Photo

New opening U-M Rogel Cancer Center by Dr @AngelQin on Gilteritinib, an acute myeloid leukaemia TKI showing promise in ALK, RET, ROS1 , sponsored by ALK Positive. More info & great update from Dr Dr Sofia Merajver, MS, MD, PhD ☮️ on Judith Tammy ALK study
youtu.be/26pTLVGuWhM?si…

account_circle
Megsie(@warriormegsie) 's Twitter Profile Photo

Y’all!!! The video (part I) I made for Bayer a few weeks ago was picked up by OncoDaily. An unexpected delight! Take a 👀 👉🏽 oncodaily.com/55589.html

Thank you bunches Bayer Oncology Medical & OncoDaily for amplifying my content for 💗🙌🏽

account_circle
Plus Therapeutics (Nasdaq: PSTV)(@plustxinc) 's Twitter Profile Photo

Exciting news yesterday as $PSTV was able to share our recent $3 Million DoD Award for our ReSPECT-PBC Pediatric Brain Cancer Trial.

Stock Region Article: bit.ly/4b4OBXG

Exciting news yesterday as $PSTV was able to share our recent $3 Million DoD Award for our ReSPECT-PBC Pediatric Brain Cancer Trial. 

Stock Region Article: bit.ly/4b4OBXG

#Nasdaq #ClinicalResearch #ClinicalTrial #PediatricOncology #BrainCancer
account_circle